Synageva BioPharma Corp (NASDAQ:GEVA)

104.73
Delayed Data
As of Apr 20
 +1.22 / +1.18%
Today’s Change
60.19
Today|||52-Week Range
122.88
+12.87%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M+0.68%
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M+0.68%
Williams Glen
Senior Vice President-Technical Operations
Sale4/08/201539,863$96.08$3.8M+8.63%
Quinn Anthony
Sale4/06/201529,503$93.76$2.8M+12.87%
Patel Sanj K
President & Chief Executive Officer
Sale12/17/201426,960$90.06$2.4M+9.05%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale10/30/201422,904$80.11$1.8M+30.81%
Goldberg Mark Alan
Sale6/11/201421,597$80.00$1.7M+29.49%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201516,716$100.74$1.7M+5.93%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201514,750$99.97$1.5M+5.93%
Williams Glen
Senior Vice President-Technical Operations
Buy4/08/201524,600$57.56$1.4M+8.63%
Page of 9

To view my watchlist

Not a member yet?

Sign up now for a free account